ClinicalTrials.Veeva

Menu

Platelet Rich Fibrin in the Treatment of Multiple Gingival Recessions

E

Ege University

Status

Completed

Conditions

Gingival Recession

Treatments

Procedure: connective tissue graft
Procedure: platelet rich fibrin

Study type

Interventional

Funder types

Other

Identifiers

NCT02018120
2012-Dis-004

Details and patient eligibility

About

The aim of this randomized controlled clinical study is to evaluate and compare the effectiveness of platelet rich fibrin (PRF) and connective tissue grafts in the treatment of multiple gingival recessions.

Full description

The aim of this randomized controlled clinical study is to evaluate and compare the effectiveness of platelet rich fibrin (PRF) and connective tissue grafts in the treatment of multiple gingival recessions.

Primary outcome variables were percentage of complete root coverage and mean root coverage percentages at 6 months follow up. The secondary outcome variables include keratinized tissue and gingival thickness gain.

Sample size has been estimated as 13 in each treatment arm. All recessions are treated with modified coronally advanced flap. On test sites PRF membrane and on control sites connective tissue grafts will be placed under modified coronally advanced flaps. Random allocation of the treatment sites to test and control groups were performed using a computer software designed for randomization.

Clinical parameters such as gingival index, plaque index, keratinized tissue width, gingival recession depth and width were measured at 1, 3 and 6 months. Probing pocket depth, clinical attachment level, gingival thickness and gingival recession area were measure at baseline and 6 months. All gingival recession-related parameters such as recession height, recession width and recession area and keratinized tissue width along with mean root coverage and complete root coverage were assessed on standardized clinical photographs using an image analysis software.

Clinical photographs were obtained at baseline and 1, 3 and 6 months after surgical intervention. 4 mm length wire was placed on gingiva to check reproducibility and to obtain standardized pictures.

Gingival tissue thickness were measured with an #15 endodontic reamer attached to rubber stopper inserted perpendicularly into the gingival tissue 2 mm below the gingival margin; thickness of the reamer will be measured with a digital caliper.

Mean root coverage percentage was calculated as percentage of covered root surface area at 6 months.

Follow up of subjects was 6 months.

Enrollment

26 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Two or more adjacent teeth with at least 2 mm Miller Class I gingival recessions at non-molar teeth
  • Identifiable CEJ on all teeth
  • Age ≥ 18
  • Presence of tooth vitality and absence of restorations and superficial caries in the treatment area
  • No past surgical treatment history of affected area.
  • Gingival thickness ≥ 0,8 mm for recession areas.
  • Sufficient palatal donor tissue for connective tissue harvesting.

Exclusion criteria

  • Smoking
  • Pregnancy or lactation
  • Systematic diseases that may affect outcomes of periodontal therapy
  • Self-reported antibiotic medication within three months
  • Occlusal trauma in treatment site

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

26 participants in 2 patient groups

connective tissue graft
Active Comparator group
Description:
connective tissue graft harvested from palatum of subjects and placed under modified coronally advanced flap
Treatment:
Procedure: connective tissue graft
Platelet rich fibrin
Experimental group
Description:
Autogenous platelet rich fibrin was obtained from subjects own blood samples after centrifugation. Platelet rich fibrin membranes were placed under modified coronally advanced flaps.
Treatment:
Procedure: platelet rich fibrin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems